Mergers & Acquisitions Archives - Page 232 of 233

Millipore jumps on reports of $6 billion Thermo Fisher buyout

February 22, 2010 By MassDevice staff Leave a Comment

Millipore Corp. (NYSE:MIL) shares soared as much as 43 percent today after news reports that Thermo Fisher Scientific (NYSE:TMO) is considering a $6 billion unsolicited bid for the Billerica, Mass.-based company.

Bloomberg News, citing a person familiar with the situation, said Millipore recently hired Goldman Sachs as its financial adviser after receiving the bid and that a deal could be agreed on as early as next week. The news service said the person did not want to be identified because the talks are not yet public.

Quidel closes Diagnostic Hybrids buyout

February 22, 2010 By MedCity News Leave a Comment

By Mary Vanac

ATHENS, Ohio — San Diego diagnostic test maker Quidel Corp. (NSDQ:QDEL) closed its acquisition of Diagnostic Hybrids Inc. for about $130 million in cash.

NeuroTherm hits the acquisitions trail again

February 12, 2010 By MassDevice staff Leave a Comment

NeuroTherm Inc. added to its portfolio of pain management technologies with the acquisition of some of a European company’s needle lines.

The Wilmington, Mass.-based medical device maker paid an undisclosed amount for Dutch firm Technomed Europe’s intellectual property and manufacturing know-how "associated with certain needle product lines," according to a press release.

NeuroTherm bought Micron Catheter last summer for an undisclosed amount, adding the Palm Beach gardens, Fla.-based company’s epidural scar removal catheter to its holdings.

Inverness to pick up Kroll substance abuse lab for $110 million

February 4, 2010 By MassDevice staff Leave a Comment

Inverness Medical Innovations Inc. (NYSE:IMA) agreed to pay $110 million in cash for Marsh & McLennan Cos. Inc. (NYSE: MMC) subsidiary Kroll Inc.’s substance abuse testing lab.

It’s the latest in a series of strategic moves for the Waltham, Mass.-based diagnostics and lab equipment maker, which has been on a buying (and selling) spree so far this year.

Thermo Fisher to acquire Finnish PCR firm

February 2, 2010 By MassDevice staff Leave a Comment

Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to pay an unspecified amount for Finnish polymerase chain reaction equipment maker Finnzyme, in a bid to bolster one of its own recent PCR assay offerings.

The Waltham, Mass.-based lab equipment maker said it inked the deal to acquire Espoo, Finland-based Finnzyme because that company’s proprietary DNA polymerases, Phire and Phusion, complement its own Solaris line of real-time quantitative PCR assays. The deal is expected to close during the first quarter.

UPDATE: Inverness closes Standard Diagnostics buyout

February 1, 2010 By MassDevice staff Leave a Comment

Inverness Medical Innovations Inc. (NYSE:IMA) is hitting the acquisitions trail hard in 2010.

The Waltham, Mass.-based diagnostics and lab equipment maker closed its deal to buy a three-quarters stake in Korean rapid diagnostics maker Standard Diagnostics (KDQ:066930) for up to $216.6 million.

Inverness bid about $35.72 per share for 75.79 percent or just more than 6 million shares of Standard Diagnostics, provided that at least roughly 2.4 million shares, or 30 percent of the total issued, were tendered.

Thoratec buys heart pump technology from Swedish firm

January 26, 2010 By MassDevice staff Leave a Comment

Thoratec Corp. (NSDQ:THOR) has struck a deal to acquire catheter-pump technology from a Swedish company for $8.5 million in cash.

The percutaneous heart pump first developed by Getinge AB (OMX:GIND-B) is driven by an external motor using a flexible drive shaft and has shown the ability to move over 4.5 liters per minute during laboratory tests. Executives at Pleasanton, Calif.-based Thoratec said the acquired technology will be used to further development on axial-flow pumps that would be placed into the heart through minimally invasive catheter procedures.

Spire closes hemodialysis catheter business sale to C.R. Bard

January 25, 2010 By MassDevice staff Leave a Comment

Spire Corp. (NSDQ:SPIR) closed the sale of its hemodialysis catheter business to a division of C.R. Bard (NYSE:BCR) Dec. 16, after postponing the merger several times and agreeing to accept $2.5 million less than the original offer.

In September 2009, Spire agreed to sell the seven-year-old operation to the Salt Lake City-based device maker’s Bard Access Systems division for $15 million, so it could focus on its core solar energy business.

Medtronic to pay up to $500 million for Italy’s Invatec, affiliates

January 25, 2010 By MassDevice staff Leave a Comment

Medtronic Inc. (NYSE:MDT) agreed to acquire Italian cardiovascular device maker Invatec and a pair of its affiliates for up to $500 million.

The Minneapolis-based medical device monolith said it will buy Invatec, which makes stents, angioplasty balloons and accessories, along with Fogazzi, Invatec’s corporate predecessor, and Krauth Cardiovascular, which distributes Invatec products in Germany.

Quidel Corp. to buy Diagnostic Hybrids for $130 million

January 12, 2010 By MedCity News Leave a Comment

By Mary Vanac

ATHENS, Ohio — Quidel Corp., the San Diego, Calif.-based company that makes point-of-care diagnostic tests, agreed to acquire Diagnostic Hybrids Inc. of Athens, Ohio, for $130 million in cash.

Started in 1983 by a group of Ohio University professors, Diagnostic Hybrids was spun out of the university to commercialize its sophisticated diagnostic tests used mostly by hospital and reference laboratories.

UPDATE: Thermo Fisher closes B.R.A.H.M.S. buyout, launches first product

October 26, 2009 By MassDevice staff Leave a Comment

The ink was hardly dried on the paperwork for Thermo Fisher Scientific Inc.‘s deal to acquire German in-vitro diagnostics maker B.R.A.H.M.S. AG for roughly $470 million before the union’s first product hit the market.